Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 39, 2010 - Issue 4-5
429
Views
92
CrossRef citations to date
0
Altmetric
Research Articles

Emerging Roles of T Helper Subsets in the Pathogenesis of Asthma

&
Pages 526-549 | Published online: 07 May 2010

REFERENCES

  • Aarvak, T., Chabaud, M., Miossec, P., Natvig, J. B. (1999). IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J. Immunol. 162:1246–1251.
  • Abbas, A. K., Murphy, K. M., Sher, A. (1996). Functional diversity of helper T lymphocytes. Nature 383:787–793.
  • Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J., Gurney, A. L. (2003). Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910–1914.
  • Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., Thunberg, S., Deniz, G., Valenta, R., Fiebig, H., (2004). Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199:1567–1575.
  • Alvarez, M. J., Olaguibel, J. M., Garcia, B. E., Rodriquez, A., Tabar, A. I., Urbiola, E. (2000a). Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Allergy 55:355–362.
  • Alvarez, M. J., Olaguibel, J. M., Garcia, B. E., Tabar, A. I., Urbiola, E. (2000b). Comparison of allergen-induced changes in bronchial hyperresponsiveness and airway inflammation between mildly allergic asthma patients and allergic rhinitis patients. Allergy 55:531–539.
  • Anderson, G. P. (2008). Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372:1107–1119.
  • Anderson, G. P., Coyle, A. J. (1994). TH2 and ‘TH2-like’ cells in allergy and asthma: pharmacological perspectives. Trends Pharmacol. Sci. 15:324–332.
  • Azzawi, M., Bradley, B., Jeffery, P.K., Frew, A.J., Wardlaw, A.J., Knowles, G., Assoufi, B., Collins, J.V., Durham, S., Kay, A.B. (1990). Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142:1407–1413.
  • Barczyk, A., Pierzchala, W., Sozanska, E. (2003). Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97:726–733.
  • Barrett, N. A., Austen, K. F. (2009). Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 31:425–437.
  • Barrios, R. J., Kheradmand, F., Batts, L., Corry, D. B. (2006). Asthma: pathology and pathophysiology. Arch. Pathol. Lab. Med. 130:447–451.
  • Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., Kuchroo, V. K. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238.
  • Bettelli, E., Korn, T., Oukka, M., Kuchroo, V. K. (2008). Induction and effector functions of T(H)17 cells. Nature 453:1051–1057.
  • Boguniewicz, M., Martin, R. J., Martin, D., Gibson, U., Celniker, A., Williams, M., Leung, D. Y. (1995). The effects of nebulized recombinant interferon-gamma in asthmatic airways. J. Allergy Clin. Immunol. 95:133–135.
  • Bryan, S. A., O’Connor, B. J., Matti, S., Leckie, M. J., Kanabar, V., Khan, J., Warrington, S. J., Renzetti, L., Rames, A., Bock, J. A., (2000). Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356:2149–2153.
  • Bullens, D. M., Truyen, E., Coteur, L., Dilissen, E., Hellings, P. W., Dupont, L. J., Ceuppens, J. L. (2006). IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir. Res. 7:135.
  • Burrows, B., Martinez, F. D., Halonen, M., Barbee, R. A., Cline, M. G. (1989). Association of asthma with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med. 32:271–277.
  • Bush, K. A., Farmer, K. M., Walker, J. S., Kirkham, B. W. (2002). Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein. Arthritis Rheum. 46:802–805.
  • Cembrzynska-Nowak, M., Szklarz, E., Inglot, A. D., Teodorczyk-Injeyan, J. A. (1993). Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am. Rev. Respir. Dis. 147:291–295.
  • Chakir, J., Shannon, J., Molet, S., Fukakusa, M., Elias, J., Laviolette, M., Boulet, L. P., and Hamid, Q. (2003). Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J. Allergy Clin. Immunol. 111:1293–1298.
  • Chen, Y., Thai, P., Zhao, Y. H., Ho, Y. S., DeSouza, M. M., Wu, R. (2003). Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J. Biol. Chem. 278:17036–17043.
  • Cheng, G., Arima, M., Honda, K., Hirata, H., Eda, F., Yoshida, N., Fukushima, F., Ishii, Y., Fukuda, T. (2002). Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am. J. Respir. Crit. Care Med. 166:409–416.
  • Cheung, P. F., Wong, C. K., Lam, C. W. (2008). Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J. Immunol. 180: 5625–5635.
  • Cho, S. H., Stanciu, L. A., Holgate, S. T., Johnston, S. L. (2005). Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am. J. Respir. Crit. Care Med. 171:224–230.
  • Coffman, R.L., Seymour, B. W., Lebman, D. A., Hiraki, D. D., Christiansen, J. A., Shrader, B., Cherwinski, H. M., Savelkoul, H. F., Finkelman, F. D., Bond, M. W., (1988). The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102:5–28.
  • Cohn, L., Elias, J. A., Chupp, G. L. (2004). Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22:789–815.
  • Cohn, L., Homer, R. J., Marinov, A., Rankin, J., Bottomly, K. (1997). Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186:1737–1747.
  • Cohn, L., Tepper, J. S., Bottomly, K. (1998). IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161:3813–3816.
  • Corren, J. (1997). Allergic rhinitis and asthma: how important is the link? J. Allergy Clin. Immunol. 99:S781–786.
  • Corrigan, C. Jand Kay, A. B. (1990). CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am. Rev. Respir. Dis. 141, 970–977.
  • Coyle, A. J., Le Gros, G., Bertrand, C., Tsuyuki, S., Heusser, C. H., Kopf, M., Anderson, G. P. (1995). Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am. J. Respir. Cell Mol. Biol. 13:54–59.
  • Coyle, A. J., Tsuyuki, S., Bertrand, C., Huang, S., Aguet, M., Alkan, S. S., Anderson, G. P. (1996). Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile. J. Immunol. 156:2680–2685.
  • Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., (2003). Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744–748.
  • Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I. C., (2008). IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 9:1347–1355.
  • Douwes, J., Gibson, P., Pekkanen, J., Pearce, N. (2002). Non-eosinophilic asthma: importance and possible mechanisms. Thorax 57:643–648.
  • Durrant, D. M., Gaffen, S. L., Riesenfeld, E. P., Irvin, C. G., Metzger, D. W. (2009). Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J. Immunol. 183:5293–5300.
  • Erpenbeck, V. J., Hohlfeld, J. M., Discher, M., Krentel, H., Hagenberg, A., Braun, A., Krug, N. (2003a). Increased expression of interleukin-9 messenger RNA after segmental allergen challenge in allergic asthmatics. Chest 123:370S.
  • Erpenbeck, V. J., Hohlfeld, J. M., Volkmann, B., Hagenberg, A., Geldmacher, H., Braun, A., Krug, N. (2003b). Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J. Allergy Clin. Immunol. 111:1319–1327.
  • Fanta, C. H. (2009). Asthma. N. Engl. J. Med. 360:1002–1014.
  • Finotto, S., Neurath, M. F., Glickman, J. N., Qin, S., Lehr, H. A., Green, F. H., Ackerman, K., Haley, K., Galle, P. R., Szabo, S. J., (2002). Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295:336–338.
  • Fu, C. L., Chuang, Y. H., Chau, L. Y., Chiang, B. L. (2006). Effects of adenovirus-expressing IL-10 in alleviating airway inflammation in asthma. J. Gene Med. 8: 1393–1399.
  • Fujiwara, M., Hirose, K., Kagami, S., Takatori, H., Wakashin, H., Tamachi, T., Watanabe, N., Saito, Y., Iwamoto, I., Nakajima, H. (2007). T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J. Allergy Clin. Immunol. 119:662–670.
  • Galli, S. J. (1997). Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J. Exp. Med. 186:343–347.
  • Gavett, S. H., Chen, X., Finkelman, F., Wills-Karp, M. (1994). Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10:587–593.
  • Green, R. H., Brightling, C. E., Woltmann, G., Parker, D., Wardlaw, A. J., Pavord, I.D. (2002). Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 57:875–879.
  • Grunig, G., Corry, D. B., Leach, M. W., Seymour, B. W., Kurup, V. P., Rennick, D. M. (1997). Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185:1089–1099.
  • Hansen, G., Berry, G., DeKruyff, R. H., Umetsu, D. T. (1999). Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:175–183.
  • Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., Weaver, C. T. (2005). Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123–1132.
  • Hashimoto, T., Akiyama, K., Kobayashi, N., Mori, A. (2005). Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int. Arch. Allergy Immunol. 137 Suppl. 1:51–54.
  • He, R., Oyoshi, M. K., Jin, H., Geha, R. S. (2007). Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc..Natl. Acad. Sci. USA 104:15817–15822.
  • Hellings, P. W., Kasran, A., Liu, Z., Vandekerckhove, P., Wuyts, A., Overbergh, L., Mathieu, C., Ceuppens, J. L. (2003). Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 28:42–50.
  • Holgate, S. T. (2008). Pathogenesis of asthma. Clin. Exp. Allergy 38:872–897.
  • Holgate, S. T., Polosa, R. (2008). Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 8:218–230.
  • Infante-Duarte, C., Horton, H. F., Byrne, M. C., Kamradt, T. (2000). Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165:6107–6115.
  • Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J. J., Cua, D. J., Littman, D. R. (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121–1133.
  • Iwamoto, I., Kumano, K., Kasai, M., Kurasawa, K., Nakao, A. (1996). Interleukin-12 prevents antigen-induced eosinophil recruitment into mouse airways. Am. J. Respir. Crit. Care Med. 154:1257–1260.
  • John, M., Lim, S., Seybold, J., Jose, P., Robichaud, A., O’Connor, B., Barnes, P. J., Chung, K. F. (1998). Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med. 157:256–262.
  • Kawaguchi, M., Kokubu, F., Kuga, H., Matsukura, S., Hoshino, H., Ieki, K., Imai, T., Adachi, M., Huang, S. K. (2001a). Modulation of bronchial epithelial cells by IL-17. J. Allergy Clin. Immunol. 108:804–809.
  • Kawaguchi, M., Onuchic, L. F., Li, X. D., Essayan, D. M., Schroeder, J., Xiao, H. Q., Liu, M. C., Krishnaswamy, G., Germino, G., Huang, S. K. (2001b). Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J. Immunol. 167:4430–4435.
  • Kay, A. B. (1997). T cells as orchestrators of the asthmatic response. Ciba Found. Symp. 206, 56–67; discussion 67–70:106–110.
  • Kay, A. B. (2006). The role of T lymphocytes in asthma. Chem. Immunol. Allergy 91: 59–75.
  • Kearley, J., Barker, J. E., Robinson, D. S., Lloyd, C. M. (2005). Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med. 202:1539–1547.
  • Kearley, J., Robinson, D. S., Lloyd, C.M. (2008). CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J. Allergy Clin. Immunol. 122:617–624, e616.
  • Kiley, J., Smith, R., Noel, P. (2007). Asthma phenotypes. Curr. Opin. Pulm. Med. 13:19–23.
  • Kips, J. C., Brusselle, G. J., Joos, G. F., Peleman, R. A., Tavernier, J. H., Devos, R. R., Pauwels, R. A. (1996). Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 153:535–539.
  • Kolls, J. K., Kanaly, S. T., Ramsay, A. J. (2003). Interleukin-17: an emerging role in lung inflammation. Am. J. Respir. Cell Mol. Biol. 28:9–11.
  • Laan, M., Cui, Z. H., Hoshino, H., Lotvall, J., Sjostrand, M., Gruenert, D. C., Skoogh, B. E., Linden, A. (1999). Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162:2347–2352.
  • Laan, M., Palmberg, L., Larsson, K., Linden, A. (2002). Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur. Respir. J. 19:534–537.
  • Lane, S.J., and Lee, T.H. (1996). Mast cell effector mechanisms. J. Allergy Clin. Immunol. 98:S67–71; discussion S71–72.
  • Larche, M. (2007). Regulatory T cells in allergy and asthma. Chest 132:1007–1014.
  • Larche, M., Robinson, D. S., Kay, A. B. (2003). The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 111:450–463; quiz 464.
  • Leckie, M. J., ten Brinke, A., Khan, J., Diamant, Z., O’Connor, B. J., Walls, C. M., Mathur, A. K., Cowley, H. C., Chung, K. F., Djukanovic, R., (2000). Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356:2144–2148.
  • Lewkowich, I. P., Herman, N. S., Schleifer, K. W., Dance, M. P., Chen, B. L., Dienger, K. M., Sproles, A. A., Shah, J. S., Kohl, J., Belkaid, Y., Wills-Karp, M. (2005). CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J. Exp. Med. 202:1549–1561.
  • Lim, S., Crawley, E., Woo, P., Barnes, P. J. (1998). Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 352:113.
  • Liu, Y., Teige, I., Birnir, B., Issazadeh-Navikas, S. (2006). Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 12:518–525.
  • Longphre, M., Li, D., Gallup, M., Drori, E., Ordonez, C. L., Redman, T., Wenzel, S., Bice, D. E., Fahy, J. V., Basbaum, C. (1999). Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J. Clin. Invest. 104:1375–1382.
  • Louten, J., Boniface, K., de Waal Malefyt, R. (2009). Development and function of TH17 cells in health and disease. J. Allergy Clin. Immunol. 123:1004–1011.
  • Lu, L. F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino-Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L., Van Snick, J., (2006). Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442:997–1002.
  • Manel, N., Unutmaz, D., Littman, D. R. (2008). The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9:641–649.
  • Mangan, P. R., Harrington, L. E., O’Quinn, D.B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., Weaver, C. T. (2006). Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231–234.
  • Masoli, M., Fabian, D., Holt, S., Beasley, R. (2004). The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59:469–478.
  • Matangkasombut, P., Pichavant, M., Dekruyff, R. H., Umetsu, D. T. (2009). Natural killer T cells and the regulation of asthma. Mucosal Immunol. 2:383–392.
  • McLane, M. P., Haczku, A., van de Rijn, M., Weiss, C., Ferrante, V., MacDonald, D., Renauld, J. C., Nicolaides, N. C., Holroyd, K. J., Levitt, R. C. (1998). Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am. J. Respir. Cell Mol. Biol. 19:713–720.
  • McMillan, S. J., Bishop, B., Townsend, M. J., McKenzie, A. N., Lloyd, C. M. (2002). The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J. Exp. Med. 195:51–57.
  • Molet, S., Hamid, Q., Davoine, F., Nutku, E., Taha, R., Page, N., Olivenstein, R., Elias, J., Chakir, J. (2001). IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108:430–438.
  • Molet, S. M., Hamid, Q. A., Hamilos, D. L. (2003). IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope 113:1803–1812.
  • Munthe-Kaas, M. C., Carlsen, K. H., Haland, G., Devulapalli, C. S., Gervin, K., Egeland, T., Carlsen, K. L., Undlien, D. (2008). T cell-specific T-box transcription factor haplotype is associated with allergic asthma in children. J. Allergy Clin. Immunol. 121:51–56.
  • Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., Cua, D. J. (2003). Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951–1957.
  • Nakae, S., Ho, L. H., Yu, M., Monteforte, R., Iikura, M., Suto, H., Galli, S. J. (2007). Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J. Allergy Clin. Immunol. 120:48–55.
  • Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., Iwakura, Y. (2002). Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375–387.
  • Nakae, S., Nambu, A., Sudo, K., Iwakura, Y. (2003). Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171:6173–6177.
  • Nakao, F., Ihara, K., Kusuhara, K., Sasaki, Y., Kinukawa, N., Takabayashi, A., Nishima, S., Hara, T. (2001). Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J. Allergy Clin. Immunol. 107:499–504.
  • O’Garra, A., Barrat, F. J., Castro, A. G., Vicari, A., Hawrylowicz, C. (2008). Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev. 223:114–131.
  • Oboki, K., Ohno, T., Saito, H., Nakae, S. (2008). Th17 and allergy. Allergol Int. 57:121–134.
  • Oda, N., Canelos, P. B., Essayan, D. M., Plunkett, B. A., Myers, A. C., Huang, S. K. (2005). Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am. J. Respir. Crit. Care Med. 171:12–18.
  • Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., Dong, C. (2005). A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133–1141.
  • Raby, B. A., Hwang, E. S., Van Steen, K., Tantisira, K., Peng, S., Litonjua, A., Lazarus, R., Giallourakis, C., Rioux, J. D., Sparrow, D., (2006). T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 173:64–70.
  • Rahman, M. S., Yamasaki, A., Yang, J., Shan, L., Halayko, A. J., Gounni, A. S. (2006). IL-17A induces eotaxin-1/CC chemokine ligand 11 expression in human airway smooth muscle cells: role of MAPK (Erk1/2, JNK, and p38) pathways. J. Immunol. 177:4064–4071.
  • Reisinger, J., Triendl, A., Kuchler, E., Bohle, B., Krauth, M. T., Rauter, I., Valent, P., Koenig, F., Valenta, R., Niederberger, V. (2005). IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation. J. Allergy Clin. Immunol. 115:973–981.
  • Robinson, D. S. (2009). Regulatory T cells and asthma. Clin. Exp. Allergy 39:1314–1323.
  • Robinson, D. S., Bentley, A. M., Hartnell, A., Kay, A. B., Durham, S. R. (1993). Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax 48:26–32.
  • Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., Kay, A. B. (1992). Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298–304.
  • Rossi, G. L., Olivieri, D. (1997). Does the mast cell still have a key role in asthma? Chest 112:523–529.
  • Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., Jr., (2008). Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28:546–558.
  • Schnyder-Candrian, S., Togbe, D., Couillin, I., Mercier, I., Brombacher, F., Quesniaux, V., Fossiez, F., Ryffel, B., Schnyder, B. (2006). Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203:2715–2725.
  • Schwarze, J., Hamelmann, E., Cieslewicz, G., Tomkinson, A., Joetham, A., Bradley, K., Gelfand, E. W. (1998). Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J. Allergy Clin. Immunol. 102:86–93.
  • Schwarzenberger, P., La Russa, V., Miller, A., Ye, P., Huang, W., Zieske, A., Nelson, S., Bagby, G. J., Stoltz, D., Mynatt, R. L., (1998). IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 161:6383–6389.
  • Sharkhuu, T., Matthaei, K. I., Forbes, E., Mahalingam, S., Hogan, S. P., Hansbro, P. M., Foster, P. S. (2006). Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity. Clin. Exp. Allergy 36:1575–1583.
  • Shimbara, A., Christodoulopoulos, P., Soussi-Gounni, A., Olivenstein, R., Nakamura, Y., Levitt, R. C., Nicolaides, N. C., Holroyd, K. J., Tsicopoulos, A., Lafitte, J. J., (2000). IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J. Allergy Clin. Immunol. 105:108–115.
  • Simpson, J. L., Grissell, T. V., Douwes, J., Scott, R. J., Boyle, M. J., Gibson, P. G. (2007). Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 62:211–218.
  • Simpson, J. L., Scott, R., Boyle, M. J., Gibson, P. G. (2006). Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 11: 54–61.
  • Soroosh, P., Doherty, T. A. (2009). Th9 and allergic disease. Immunology 127:450–458.
  • Steinman, L. (2007). A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13:139–145.
  • Temann, U. A., Geba, G. P., Rankin, J. A., Flavell, R. A. (1998). Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J. Exp. Med. 188:1307–1320.
  • Till, S. J., Francis, J. N., Nouri-Aria, K., Durham, S. R. (2004). Mechanisms of immunotherapy. J, Allergy Clin. Immunol. 113:1025–1034; quiz 1035.
  • Tsicopoulos, A., Shimbara, A., de Nadai, P., Aldewachi, O., Lamblin, C., Lassalle, P., Walls, A. F., Senechal, S., Levitt, R. C., Darras, J., (2004). Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J. Allergy Clin. Immunol. 113:462–469.
  • Umetsu, D. T., McIntire, J. J., Akbari, O., Macaubas, C., DeKruyff, R. H. (2002). Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715–720.
  • van de Kant, K. D., Klaassen, E. M., Jobsis, Q., Nijhuis, A. J., van Schayck, O. C., Dompeling, E. (2009). Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study. BMC Publ. Health 9:210.
  • Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., Stockinger, B. (2006). TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179–189.
  • Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., Stockinger, B. (2008). Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9:1341–1346.
  • Vignola, A. M., Chanez, P., Campbell, A. M., Souques, F., Lebel, B., Enander, I., Bousquet, J. (1998). Airway inflammation in mild intermittent and in persistent asthma. Am. J. Respir. Crit. Care Med. 157:403–409.
  • Wakashin, H., Hirose, K., Maezawa, Y., Kagami, S., Suto, A., Watanabe, N., Saito, Y., Hatano, M., Tokuhisa, T., Iwakura, Y., (2008). IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 178:1023–1032.
  • Walker, C., Bauer, W., Braun, R. K., Menz, G., Braun, P., Schwarz, F., Hansel, T. T., Villiger, B. (1994). Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 150:1038–1048.
  • Wang, J., Homer, R. J., Chen, Q., Elias, J. A. (2000). Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J. Immunol. 165:4051–4061.
  • Wenzel, S., Wilbraham, D., Fuller, R., Getz, E. B., Longphre, M. (2007). Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet 370:1422–1431.
  • Wenzel, S. E., Schwartz, L. B., Langmack, E. L., Halliday, J. L., Trudeau, J. B., Gibbs, R. L., Chu, H. W. (1999). Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am. J. Respir. Crit. Care Med. 160:1001–1008.
  • Wilder, J. A., Collie, D. D., Bice, D. E., Tesfaigzi, Y., Lyons, C. R., Lipscomb, M. F. (2001). Ovalbumin aerosols induce airway hyperreactivity in naive DO11.10 T cell receptor transgenic mice without pulmonary eosinophilia or OVA-specific antibody. J. Leukoc. Biol. 69:538–547.
  • Wills-Karp, M. (1999). Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255–281.
  • Wing, K., Fehervari, Z., Sakaguchi, S. (2006). Emerging possibilities in the development and function of regulatory T cells. Int. Immunol. 18:991–1000.
  • Wong, C. K., Ho, C. Y., Ko, F. W., Chan, C. H., Ho, A. S., Hui, D. S., Lam, C. W. (2001). Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin. Exp. Immunol. 125:177–183.
  • Woolcock, A. J., Peat, J. (2000). What is the relationship between airway hyperresponsiveness and atopy? Am. J. Respir. Crit. Care Med. 161:S215–S217.
  • Ying, S., Humbert, M., Barkans, J., Corrigan, C. J., Pfister, R., Menz, G., Larche, M., Robinson, D. S., Durham, S. R., Kay, A. B. (1997). Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J. Immunol. 158:3539–3544.
  • Ying, S., Meng, Q., Kay, A. B., Robinson, D. S. (2002). Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin Exp Allergy 32:866–871.
  • Zhou, L., Chong, M. M., Littman, D. R. (2009). Plasticity of CD4+ T cell lineage differentiation. Immunity 30:646–655.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.